Vertex chief Jeffrey Leiden to weigh in on Orkambi inquiry

PM Live

4 March 2019 - Vertex’s long-running spat with NHS England has amounted to a legal inquiry scheduled to begin this Thursday, and Vertex chief Jeffrey Leiden is set to be among those cross examined.

He will be joined by the company’s chief commercial officer, Stuart Arbuckle who will also present evidence to support the company’s stance on the pricing of its cystic fibrosis (CF) drug Orkambi.

The inquiry will be led by the UK’s Health and Social Care Committee, which is aiming to resolve the stalemate between NHS England and Vertex.

Read PM Live article

Michael Wonder

Posted by:

Michael Wonder